Home Life Sciences Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
Article Open Access

Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis

  • Sun Jianwei , Zhang Guowen , Zhang Yan , Zheng Mengyang , Du Zefei and Liang Haifeng EMAIL logo
Published/Copyright: November 27, 2025

Abstract

Although there has been research on the toxicity of Rhizoma Paridis (Chong Lou), a systematic and comprehensive evaluation, as well as targeted strategies for mitigating its toxicity, remains lacking. This review aims to provide a thorough assessment of the toxicological properties of Rhizoma Paridis, offering reliable guidance for its safe application. The article focuses on the toxicity and underlying mechanisms of Rhizoma Paridis and reviews the applications of both traditional Chinese medicine and modern scientific technologies in detoxification. Finally, it proposes future research directions, emphasizing the need for further exploration of chronic toxicity mechanisms and advocating for the integration of traditional and modern detoxification methods to ensure the safe clinical use of Rhizoma Paridis. This review provides the latest theoretical foundation for the safe use and further development of Rhizoma Paridis.

1 Introduction

Rhizoma Paridis, a traditional Chinese herbal medicine, is derived from the dried rhizomes of Dian Paris (Paris polyphylla Smith var. Mazz.) and seven-leaved Paris (P. polyphylla Smith var.), both belonging to the genus Paris in the Liliaceae family [1,2]. Its medicinal properties are well-documented in classical texts of Traditional Chinese Medicine (TCM), such as the Shennong Bencao Jing [3]. Rhizoma Paridis is particularly recognized for its effects in clearing heat, detoxifying the body, reducing swelling, alleviating pain, cooling the blood, and stopping bleeding [4]. Historically, it has been used for centuries to treat a variety of conditions, including mumps, bleeding disorders, snake bites, fractures, and abscesses [5].

Pharmacological studies have demonstrated that Rhizoma Paridis possesses a range of bioactive properties, including antitumor, antimicrobial, anti-inflammatory, etc. (Figure 1) [614]. Due to these pharmacological activities, Rhizoma Paridis is commonly included in TCM formulations for both internal and external use, treating a variety of conditions such as inflammation, tumors, snake bites, and traumatic infections. Additionally, it serves as the raw material for 90 proprietary Chinese medicines and is widely used in clinical practice (Table 1) [1531].

Figure 1 
               Pharmacological activities of Rhizoma Paridis.
Figure 1

Pharmacological activities of Rhizoma Paridis.

Table 1

Representative proprietary chinese medicines containing Rhizoma Paridis

Category Drug name Effects Clinical indications Approval number
Analgesics [15,20]
Baibao Dan Dispel blood stasis and reduce swelling, stop bleeding and relieve pain Knife and gun injuries, traumatic injuries, menstrual irregularities, dysmenorrhea, amenorrhea, chronic gastralgia, and joint pain Guoyao Zhunzi Z53021108
Changchun hongyao capsule Promote blood circulation and remove blood stasis, reduce swelling and relieve pain Traumatic injuries with blood stasis and pain Guoyao Zhunzi Z20026502
Yili Zhitongwan Clear heat and detoxify, promote blood circulation, and relieve pain Pain caused by knife and gun injuries, traumatic injuries, dysmenorrhea in women, and pain associated with advanced malignant tumors Guoyao Zhunzi Z50020232
Zhongtong Qiwuji Reduce swelling, alleviate pain, promote blood circulation, remove blood stasis, relax tendons and activate collaterals, resolve masses, and disperse nodules Traumatic injuries, rheumatic joint pain, frozen shoulder, gouty arthritis, and mammary gland hyperplasia Guoyao Zhunzi Z20025741
Chanwu Babugao Promote blood circulation, remove blood stasis, reduce swelling, and relieve pain Treatment of cancer-related pain; also applicable to acute and chronic sprains, traumatic injuries, bone hyperplasia, rheumatism, and rheumatoid pain, as well as conditions like stiff neck, frozen shoulder, lumbar muscle strain, and injuries Guoyao Zhunzi Z20027885
Diedabang Yaojiu Reduce swelling and relieve pain Traumatic injuries with blood stasis, swelling, and pain Guoyao Zhunzi Z44023384
Shennong Zhentong Gao Activate blood circulation, disperse blood stasis, reduce swelling, and relieve pain Traumatic injuries, rheumatic joint pain, and lumbar and back soreness Guoyao Zhunzi Z44020387
Xiongdan Diedagao Activate blood circulation, disperse blood stasis, reduce swelling, and relieve pain Traumatic injuries, rheumatic joint pain, and lumbar and back soreness Guoyao Zhunzi Z20026055
Anticancer drugs [15,2124]
Boerning capsule Support healthy energy, expel pathogenic factors, replenish qi, activate blood circulation, soften and disperse nodules, reduce swelling, and relieve pain Adjunctive treatment for cancer Guoyao ZhunziZ20054459
Ganfule Pian Strengthen the spleen and regulate qi, resolve blood stasis, soften nodules, and clear heat and detoxify Primary liver cancer Guoyao Zhunzi Z10940066
Loulian capsule Regulate qi, dissolve blood stasis, and clear heat and detoxify Adjunctive treatment for primary liver cancer Guoyao Zhunzi Z10980133
Qizhen Capsule Replenish qi, resolve blood stasis, and clear heat and detoxify Treatment of cancers such as lung cancer, breast cancer, and gastric cancer Guoyao Zhunzi Z20010074
Ruan-Jian oral liquid Resolve blood stasis, soften nodules, detoxify, and replenish qi Primary liver cancer Guoyao Zhunzi Z20184027
Xiongdan capsule Possess the effects of clearing heat and dispersing nodules, activating blood circulation, eliminating masses, and strengthening the body Adjunctive treatment for nasopharyngeal cancer, esophageal cancer, gastric cancer, and rectal cancer Guoyao Zhunzi Z19983163
Gastrointestinal drugs [15]
Quyu Yiwei Capsule Strengthen the spleen and harmonize the stomach, resolve blood stasis, and relieve pain Gastric pain caused by spleen deficiency, qi stagnation, and blood stasis, as well as symptoms of chronic superficial gastritis Guoyao Zhunzi Z20174017
Xuedan Weichangwan Warm the middle, dispel cold, regulate qi, and relieve pain Cold deficiency in the middle burner causing gastric cold pain, belching, acid regurgitation, loose stools, gastric ulcers, duodenal ulcers, duodenitis, and proctitis Guoyao Zhunzi Z20025385
Gynecological drugs [15,2527]
Gongxuening capsule Cool the blood, stop bleeding, clear heat, eliminate dampness, and relieve pain Excessive uterine bleeding, heavy menstruation, postpartum or post-abortion uterine atony bleeding, uterine bleeding due to blood heat, and chronic pelvic inflammation causing lower abdominal pain, lumbosacral pain, and increased vaginal discharge Guoyao Zhunzi Z20020087
Sanjie Zhitonggao Soften and disperse nodules, reduce swelling, and relieve pain Cystic hyperplasia of the mammary gland, mastalgia, and gynecomastia in males Guoyao Zhunzi Z44023492
Heat-clearing and detoxification [15,28]
Hongwei Sheyaopiao Clear heat, detoxify, reduce swelling, relieve pain, cool the blood, and disperse blood stasis Used for snake bites and poisonous insect bites Guoyao Zhunzi Z36021580
Jideshengshe tablet Clear heat, detoxify, reduce swelling, and relieve pain Snake and poisonous insect bites Guoyao Zhunzi Z32020048
Zhanjiang Sheyao Neutralize snake venom, relieve pain, and reduce swelling Snake bites, centipede bites, and other poisonous insect stings Guoyao Zhunzi Z44023712
Liver-related drugs [15]
Biyunsha Yigan Keli Clear the liver, detoxify, and regulate qi and blood circulation Hepatitis B caused by liver and gallbladder damp-heat syndrome Guoyao Zhunzi Z20026322
Caoxian Yigan Capsule Clear heat, detoxify, strengthen the spleen, and drain dampness Chronic hepatitis B, flank pain, abdominal distension due to hepatitis B Guoyao Zhunzi Z20204009
Qinggan Baiduwan Clear heat, drain dampness, and detoxify Acute and chronic hepatitis due to liver and gallbladder damp-heat syndrome Guoyao Zhunzi Z20026098
Respiratory system drugs [15,29]
Xiaoer Tuire Chongji Dispel wind and release the exterior, detoxify, and relieve throat discomfort Pediatric cold and fever caused by external wind-heat, as well as upper respiratory tract infections with similar symptoms Guoyao Zhunzi Z37021424
Fufang Chuanbei Zhiketangjiang Suppress cough and resolve phlegm, moisten the lungs, and calm asthma Cold with cough, excessive phlegm, and shortness of breath Guoyao ZhunziZ44023581
Fufang Shedan Chuanbeisan Suppress cough and resolve phlegm Wind-heat cough and chronic cough with excessive phlegm Guoyao Zhunzi Z44022008
Fufang Yanlian Pian Clear heat, detoxify, dissolve phlegm, and relieve cough Cold, cough caused by upper respiratory tract infections, acute and chronic bronchitis, pharyngitis, and tonsillitis Guoyao Zhunzi Z52020427
Houshu Kouhanpian Clear heat, detoxify, moisten the lungs, and relieve throat discomfort Sore throat, throat itching, and dryness Guoyao Zhunzi Z53020605
Biyan Qingdu Ji Clear heat, detoxify, reduce inflammation, and disperse nodules Chronic inflammation of the nasopharynx, sore throat, and increased secretions after radiotherapy for nasopharyngeal cancer Guoyao Zhunzi Z44022386
Qingre Zhike Keli Clear heat, resolve phlegm, open the lungs, and relieve cough Cough with phlegm or heat-related cough Guoyao Zhunzi Z20000016
Redu Qingpian Heat-clearing detoxification tablets: clear heat, detoxify, reduce swelling, and disperse nodules Parotitis, tonsillitis, laryngitis, and upper respiratory tract infections caused by internal heat toxins Guoyao Zhunzi Z53020800
Shenbei Zhike Keli Clear the lungs, dissolve phlegm, and relieve cough Chronic bronchitis with cough Guoyao Zhunzi Z20026126
Jiuwei Shaungjie Koufuye Release the exterior and clear heat, purge fire, and detoxify Wind-heat colds Guoyao Zhunzi Z20240002
Lanhua Kening Pian Treat wind-heat attacking the lungs, clear heat, detoxify, astringe the lungs, and relieve cough Acute and chronic bronchitis, chronic cough, and scanty phlegm Guoyao Zhunzi Z20043682
Xiaoer Qingreling Clear heat, detoxify, relieve throat discomfort, and stop coughing Cold with fever, sore throat, cough, and shortness of breath Guoyao Zhunzi Z22022819
Rendong Ganmao Keli Clear heat and detoxify Fever and throat pain caused by upper respiratory tract infections Guoyao Zhunzi Z20025083
Rheumatology drugs [15]
Gufengning capsule Detoxify, dissolve blood stasis, and activate collaterals to relieve pain Rheumatoid arthritis and ankylosing spondylitis Guoyao Zhunzi Z20026229
Lujin Zhuanggu Jiu Dispel wind and dampness, relax muscles, and activate blood circulation Numbness of limbs and rheumatic arthritis Guoyao Zhunzi Z22024875
Xuanqi Tongbi Capsule Nourish and tonify the liver and kidneys, activate blood circulation, remove stasis, reduce swelling, and relieve pain Rheumatoid arthritis Guoyao Zhunzi Z19990041
Jingutengtong Jiu Expel wind and dampness, relax muscles, and activate blood circulation Muscular and joint pain, limb numbness, and rheumatic arthritis Guoyao ZhunziZ34020072
Skin, eczema, and dermatitis drugs [15,30]
Jianghuang Xiaocuo Chaji Clear heat, eliminate dampness, and promote blood circulation to treat acne Acne (pimples) Guoyao Zhunzi Z20025149
Yinbing Xiaocuoting Clear heat, detoxify, cool the blood, and reduce swelling Acne Guoyao Zhunzi Z20025294
Keyangminxu Astringe to stop itching, reduce inflammation, and detoxify Acute and chronic eczema, urticaria, insect-bite dermatitis, contact dermatitis, and skin itching Guoyao Zhunzi Z44022982
Chonglou Jieduting Clear heat, detoxify, and relieve pain by dispersing blood stasis Herpes zoster, skin itching, insect-bite dermatitis, and epidemic parotitis Guoyao Zhunzi Z20025808
Xiaozhi Jiefu Ruangao Clear heat, detoxify, resolve blood stasis, reduce swelling, and eliminate dampness to stop itching Athlete's foot, body ringworm, groin ringworm, damp sores, internal and external hemorrhoids with swelling, pain, and bleeding caused by damp-heat accumulation ZF018200
Trauma and hemostasis [15,31]
Yunnan Baiyao Stop bleeding, relieve pain, reduce inflammation, and promote wound healing Small open wounds in surgery Guoyao Zhunzi Z53021102
Shangyi Qiwuji Reduce swelling, relieve pain, stop bleeding, and disperse blood stasis Traumatic injuries and mild burns or scalds Guoyao Zhunzi Z20026238
Yunnanhongyao capsule Stop bleeding and relieve pain, promote blood circulation, disperse blood stasis, and expel wind and dampness Gastric ulcer bleeding, bronchiectasis with hemoptysis, functional uterine bleeding, menorrhagia, fundus hemorrhage, conjunctival hemorrhage, epistaxis, hemorrhoidal bleeding, soft tissue contusions, rheumatic arthritis, and rheumatic lumbar-leg pain Guoyao Zhunzi Z53020129
Sanqi Xueshangning Capsule Stop bleeding and relieve pain, remove stasis, and promote tissue regeneration Gastric and duodenal ulcer bleeding, bronchiectasis bleeding, pulmonary tuberculosis with hemoptysis, functional uterine bleeding, trauma and hemorrhoidal bleeding, menstrual disorders, dysmenorrhea, amenorrhea, excessive menstrual bleeding, postpartum blood stasis, gastric disorders, and intercostal neuralgia Guoyao Zhunzi Z45020612
Urinary system drugs [15]
Jiedutonglin Wan Clear heat, eliminate dampness, and promote urination Non-gonococcal urethritis caused by lower burner damp-heat Guoyao Zhunzi Z20025507
Niaoqingshu Keli Clear heat, drain dampness, and promote urination Acute and chronic prostatitis, urinary tract infections, cystitis, and other urological conditions Guoyao Zhunzi Z20026440
Others [15]
Waiyong Wudigao Expel wind, remove dampness, activate blood circulation, reduce swelling, relieve pain, clear heat, detoxify, and relieve obstruction and pain Traumatic injuries, rheumatic numbness, lumbar and shoulder pain, and abscesses with redness, swelling, and pain Guoyao Zhunzi Z53020661
Weisheng San Remove filth, clear heat, detoxify, relieve spasms, and calm the mind High fever with coma, neck stiffness with convulsions, stroke with phlegm retention causing jaw clenching and phlegm obstruction, pediatric convulsions, acute gastroenteritis, vomiting, diarrhea, abscesses, and carbuncles Guoyao Zhunzi Z21022012

Despite its significant medicinal benefits, the potential toxicity of Rhizoma Paridis must not be overlooked. Research has identified several chemical compounds, including steroidal saponins and alkaloids, which contribute to its therapeutic effects but may also trigger toxic reactions [32]. Therefore, it is crucial to understand the toxic constituents and the mechanisms underlying their toxicity to ensure the safe use of Rhizoma Paridis in medical practice. Comprehensive studies on its toxicity, as well as strategies for prevention and detoxification, are essential not only for advancing the modernization of traditional medicine but also for promoting the safe and rational application of Rhizoma Paridis.

This study provides a systematic examination of the chemical composition, toxicological profiles, and mechanisms of toxicity associated with Rhizoma Paridis. It further investigates prevention and detoxification strategies, methods of toxicity assessment, and potential directions for future research. The findings aim to offer a comprehensive framework for ensuring the safe application of Rhizoma Paridis in clinical practice and guiding further scientific exploration.

2 Chemical composition of Rhizoma Paridis

Rhizoma Paridis contains a diverse range of natural compounds. To date, more than 200 chemical constituents have been isolated and identified from Rhizoma Paridis [3335].

2.1 Steroidal saponins

Steroidal saponins are the primary active compounds in Rhizoma Paridis, renowned for their diverse biological activities [36,37]. Their chemical structure, which resembles that of steroid hormones, allows them to exert various pharmacological effects in the body. To date, 136 distinct steroidal saponins have been isolated and identified from Rhizoma Paridis, with spirostanol and furostanol being the most predominant, together accounting for approximately 80% of the total saponins [3842]. Notable examples of these saponins include Polyphyllin I (PPI), Polyphyllin II (PPII), and Polyphyllin VII (PPVII).

2.2 C21 steroids

C21 steroids have attracted considerable attention due to their distinctive chemical structures and a wide range of pharmacological effects, including antitumor, anti-inflammatory, sedative, and analgesic properties [4345]. As key constituents of Rhizoma Paridis, these compounds are responsible for many of its biological activities [46].

2.3 Flavonoid

Flavonoids are lipophilic constituents of Rhizoma Paridis [47]. Although present in relatively low concentrations, these compounds demonstrate notable antioxidant and anti-inflammatory activities. Their effects are primarily mediated through the scavenging of free radicals and the inhibition of inflammatory mediator release [48].

2.4 Others

In addition to the aforementioned components, Rhizoma Paridis contains other classes of compounds, including plant growth regulators, plant sterols, quinones, fatty acids, alkaloids, and phenylpropanoids, as identified in relevant pharmaceutical research [49].

3 Toxicological studies on Rhizoma Paridis

Although Rhizoma Paridis plays a significant therapeutic role in clinical practice, there remains a limited understanding of its toxicity and the underlying mechanisms of its toxic effects. This section reviews and analyzes previous studies to provide a comprehensive understanding of the toxicological properties of Rhizoma Paridis, offering a theoretical foundation and data support for future research.

3.1 Hepatotoxicity

The liver is the primary organ for drug metabolism in the body and is also a key target for drug-induced toxicity [5052]. Hepatotoxicity is a common cause of liver damage, manifesting in a variety of clinical symptoms [53,54]. A thorough understanding of the hepatotoxic effects of TCMs is crucial, particularly in the context of new drug development and clinical drug use, to ensure safety assessments and minimize drug-induced liver damage. The following sections will discuss in detail the clinical manifestations and specific mechanisms by which Rhizoma Paridis saponins induce hepatocellular injury.

3.1.1 Clinical manifestations

Rhizoma Paridis is a toxic herb, and its hepatotoxicity exhibits a clear dose-dependent relationship. Experimental studies have shown that when the total saponin dose exceeds 4–5 times the recommended amount, significant liver damage occurs. For instance, in a zebrafish model, high doses of Rhizoma Paridis saponins caused scattered necrosis in liver tissue, disrupted hepatocyte arrangement, and triggered apoptosis and vacuolation. Additionally, in rat models, when the total saponin dose exceeded 265 mg/kg (approximately five times the equivalent dose for humans), noticeable hepatocellular damage was observed. Histopathological analysis of liver tissue revealed the disappearance of hepatocyte membranes, cell enlargement, prominent binucleation, and severe nuclear fragmentation. These pathological changes further confirm the hepatotoxic effects of Rhizoma Paridis saponins [55].

3.1.2 Mechanisms of hepatotoxicity

3.1.2.1 Induction of apoptosis

Apoptosis is a key mechanism underlying liver injury induced by Rhizoma Paridis. Studies have shown that Rhizoma Paridis triggers hepatocyte apoptosis by activating both intrinsic (mitochondrial) and extrinsic (death receptor) apoptotic pathways. These pathways ultimately converge on a caspase cascade, leading to hepatocellular death. Additionally, oxidative stress and the generation of reactive oxygen species (ROS) exacerbate the apoptotic process (Figure 2) [56,57].

  1. Intrinsic pathway: Mitochondrial pathway

    Mitochondria are the primary source of ROS within cells. PPⅡ stimulates the production of ROS in mitochondria, inducing oxidative stress. Excessive ROS not only directly damage cellular lipids, proteins, and DNA, but also activate the tumor suppressor protein p53. p53 serves as a DNA damage sensor, and in response to ROS, it upregulates the pro-apoptotic protein Bax while downregulating the anti-apoptotic protein Bcl-2, altering the Bax/Bcl-2 ratio. This disruption leads to a loss of mitochondrial membrane potential (Δψm), increased mitochondrial membrane permeability, and the release of cytochrome c into the cytoplasm. Cytochrome c activates downstream caspases, including caspase-9 and caspase-3, which ultimately result in hepatocyte apoptosis. ROS play a crucial role in amplifying liver damage by potentiating this mitochondrial apoptotic pathway [58,59].

  2. Extrinsic pathway: Death receptor pathway

    In the extrinsic apoptotic pathway, the binding of Fas (death receptor 1) to its ligand FasL initiates the activation of caspase-8. Caspase-8 subsequently activates caspase-3 and cleaves poly (ADP-ribose) polymerase, further promoting apoptosis. PPII have been shown to upregulate Fas, Bax, and cytochrome c expression, while activating caspase-3, caspase-8, and caspase-9 in a dose- and time-dependent manner, thereby enhancing hepatocyte apoptosis [59].

Figure 2 
                        The mechanism of Rhizoma Paridis saponin-induced apoptosis in hepatocytes.
Figure 2

The mechanism of Rhizoma Paridis saponin-induced apoptosis in hepatocytes.

3.1.2.2 Impact on cytochrome P450 (CYP450) enzymes

CYP450 enzymes are essential metabolic enzymes in hepatocytes, playing a key role in the metabolism of most drugs by enhancing their polarity and water solubility [6062]. Upon entering the body, PPI can influence the CYP450 enzyme system, leading to alterations in the expression of drug-metabolizing enzymes such as CYP1A1, CYP1A2, and phase II enzymes like GSTA3. These changes in enzyme expression may disrupt normal drug metabolism, potentially contributing to liver damage.

3.1.2.3 Hepatic energy and lipid metabolism imbalance

Dysfunction in mitochondrial respiratory chain reactions and lipid metabolism in the liver are key contributors to the development of liver fibrosis and injury [6365]. Studies have shown that PPI and PPII can induce severe hepatotoxicity in a dose-dependent manner by disrupting lipid and energy metabolism pathways. These disruptions are mediated through mitochondrial dysfunction and the inhibition of key enzymes involved in lipid metabolism [66].

PPI impairs mitochondrial function by inhibiting β-oxidation, preventing the metabolism of free fatty acids. As a result, free fatty acids are converted into triglycerides, leading to lipid accumulation in the liver. The peroxisome proliferator-activated receptor (PPAR) signaling pathway, essential for lipid metabolism, is significantly affected by PPI. Both PPARα, which regulates genes involved in lipid clearance, and PPARγ, which promotes adipocyte differentiation and glucose uptake, are inhibited. This suppression reduces the activity of key enzymes in the PPAR pathway, including stearoyl-CoA desaturase-1, acyl-CoA oxidase 1, and CD36 (a fatty acid transporter), highlighting the pathway’s critical role in lipid metabolism and accumulation.

Furthermore, proteomic and transcriptomic analyses in human liver cell lines (L-02) and zebrafish models have revealed that exposure to PPI and PPII disrupts the cholesterol biosynthesis pathway, as evidenced by the downregulation of critical enzymes such as HMG-CoA reductase (HMGCR) and squalene epoxidase.

3.2 Hematotoxicity

Drug-induced hemolysis refers to the rupture and destruction of red blood cells (RBCs) caused by certain drugs or their metabolites, resulting in the release of hemoglobin into the plasma [67]. Common mechanisms include oxidative stress, immune reactions, direct toxicity, and interference with metabolic pathways [68,69]. Hemolysis can result in clinical symptoms such as anemia, jaundice, and kidney dysfunction, and in severe cases, it may be life-threatening [7072].

3.2.1 Clinical manifestations

Studies have shown that no hemolysis occurs when the concentration of total Rhizoma Paridis saponins is ≤0.01 g/L. However, when the concentration exceeds 0.01 g/L, hemolysis occurs, and its intensity is dose-dependent [73]. Fang and colleagues, using visual inspection and spectrophotometry, evaluated the hemolytic activity of total Rhizoma Paridis saponins, pennogenin saponins, and dioscin. They found that pennogenin saponins exhibited stronger hemolytic effects than dioscin, suggesting that pennogenin saponins are the primary hemolytic compounds in Rhizoma Paridis. Additionally, research indicates that compounds with similar structures, such as PPI, PPII, and PPD, also exhibit strong in vitro hemolytic activity.

Figure 3 
                     The mechanism of blood toxicity induced by Rhizoma Paridis saponins.
Figure 3

The mechanism of blood toxicity induced by Rhizoma Paridis saponins.

3.2.2 Mechanisms of hematotoxicity (Figure 3)

3.2.2.1 Binding to cholesterol on RBC membrane

The steroid saponins in Parnassia compounds may bind to cholesterol on the erythrocyte membrane, forming insoluble complexes. This binding enhances lipid peroxidation reactions within the membrane, leading to membrane structural instability. As a result, the normal osmotic pressure of the erythrocytes is disrupted, ultimately causing hemolysis due to the rupture of the RBCs [74].

3.2.3 Binding to anion channels and inhibiting GLUT1

Anion channels, such as Band 3, are essential proteins on the RBC membrane that maintain the ionic balance between the intracellular and extracellular environments [75]. Studies have shown that saponins from Rhizoma Paridis, particularly PPII, can bind to Band 3 and inhibit its transport activity. This disruption alters the ion transport function of the RBC membrane, resulting in an imbalance of ion concentrations across the membrane. As a consequence, intracellular osmotic pressure increases, leading to RBC rupture and hemolysis. Additionally, PPII may alter the structure of Band 3 and other membrane proteins, thereby damaging the RBC cytoskeleton and causing the loss of normal cell morphology and function. This damage compromises the structural integrity of the RBC membrane, causing partial detachment of membrane proteins and increasing the cell’s susceptibility to hemolysis.

Furthermore, PPII competitively inhibits GLUT1, reducing glucose transmembrane transport. This inhibition impairs the energy supply to RBCs and disrupts intracellular osmotic pressure, leading to cell swelling and rupture [76]. Studies have demonstrated that GLUT1 inhibition promotes hemolysis, further supporting the mechanism by which PPII induces hemolysis through the suppression of glucose transport.

The interaction between anion channels and GLUT1 may jointly regulate RBC morphology and function by forming protein complexes, such as the Band 3–GLUT1 interaction. By binding to both channels, PPII may alter their structure or function, disrupting the transport of ions and glucose, which exacerbates the increase in intracellular osmotic pressure, promoting RBC swelling and rupture [77].

3.2.4 Potential mechanism of polyphyllin D (PD)-induced hemolysis

Recent studies have demonstrated that PD exhibits significant blood toxicity, capable of inducing hemolysis and apoptosis in human RBCs. The mechanism underlying PD-induced hemolysis begins with the activation of calcium channels on the RBC membrane, leading to an increase in intracellular calcium ion concentration. This calcium influx promotes the externalization of phosphatidylserine, cell shrinkage, and the activation of caspase-3, which are hallmark features of apoptosis (eryptosis). In addition, PD directly affects the RBC membrane, increasing its permeability and facilitating the exchange of calcium ions between the intracellular and extracellular environments. This further amplifies the activation of the calcium-dependent apoptotic pathway. Due to its strong hemolytic and cytotoxic effects, PD’s clinical application is limited. Therefore, future research should focus on developing more efficient drug delivery systems to mitigate its toxicity to RBCs while preserving its anticancer potential [78].

3.3 Gastrointestinal toxicity

3.3.1 Clinical manifestations

Gastrointestinal toxicity induced by Rhizoma Paridis is a significant concern in its clinical application. Excessive intake of Rhizoma Paridis can result in gastrointestinal side effects, including nausea, vomiting, and diarrhea. Studies have shown that a single administration of Rhizoma Paridis saponins inhibits gastric emptying in a dose-dependent manner without affecting intestinal transit in mice, indicating gastric irritation [79].

3.3.2 Mechanisms of gastrointestinal toxicity

Research has demonstrated that the cytotoxicity of saponins is primarily due to their membrane toxicity, which may result from the depletion of cholesterol in cell membranes [74]. When saponins reach a certain concentration in the small intestine, they increase the permeability of intestinal mucosal cells, inhibit active nutrient transport, and facilitate the absorption of substances that are normally impermeable to the intestinal epithelium [80]. Despite these findings, the precise mechanisms underlying the gastrointestinal irritation caused by Rhizoma Paridis remain poorly understood. Further research is needed to ensure its effective and safe clinical use.

3.4 Cardiovascular toxicity

3.4.1 Clinical manifestations

Drug-induced cardiovascular side effects contribute significantly to morbidity and mortality rates [81]. Clinical reports indicate that excessive intake of Rhizoma Paridis can lead to cardiotoxic effects, manifesting as symptoms such as arrhythmias and muffled heart sounds. Furthermore, studies have demonstrated that three saponins – PPⅠ, PPⅡ, and PPⅦ – strongly inhibit the proliferation of cardiovascular cells, including H9c2, HUVEC, and HCMEC. Notably, PPⅠ has shown significant cardiotoxicity in both zebrafish and mouse models, suggesting a potential risk of cardiovascular damage [82].

3.4.2 Mechanisms of cardiovascular toxicity

The cardiovascular toxicity of Rhizoma Paridis is primarily associated with a significant inhibition of cell viability, migration, invasion, and angiogenesis. The underlying mechanisms of PPI-induced cardiovascular toxicity occur via two major pathways: inhibition of angiogenesis and induction of endothelial cell apoptosis.

First, PPI suppresses the tyrosine phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), thereby reducing VEGF signaling. This, in turn, inhibits endothelial cell proliferation and migration through several downstream signaling pathways, including PI3K/Akt/mTOR, Src/eNOS, p38, and PLCγ/ERK/MEK. These effects ultimately block new blood vessel formation. Additionally, PPI inhibits the JAK2/STAT3 signaling pathway, further suppressing endothelial cell activity and reducing angiogenesis.

Second, PPI induces apoptosis in cardiovascular cells, as evidenced by the release of lactate dehydrogenase, morphological changes such as apoptotic body formation and chromatin condensation, and cell cycle arrest, particularly in the S and G2/M phases, leading to cell death. At the molecular level, PPI upregulates Bax, downregulates Bcl-2, and activates caspase-9, thereby initiating the mitochondrial pathway to induce apoptosis.

In summary, PPI likely exerts cardiovascular toxicity through the combined effects of multiple signaling pathways, inhibiting angiogenesis and inducing endothelial cell apoptosis (Figure 4) [83].

Figure 4 
                     The mechanism of cardiovascular toxicity induced by Rhizoma Paridis saponins.
Figure 4

The mechanism of cardiovascular toxicity induced by Rhizoma Paridis saponins.

3.5 Reproductive toxicity

Shen et al. investigated the effects of Rhizoma Paridis on sperm viability through in vitro sperm incubation. Their study found that pennogenin saponins and dioscin, isolated and purified from Rhizoma Paridis, significantly reduced sperm viability in mice. At a final concentration of 40 mg/L, dioscin completely killed all sperm, while some sperm remained viable when exposed to pennogenin saponins at the same concentration [84]. However, it is important to note that Rhizoma Paridis has not undergone systematic reproductive toxicity studies in accordance with international and national guidelines [85]. Most existing studies have focused on reproductive organ toxicity, indicating potential reproductive risks but failing to precisely characterize the types and severity of toxicity (e.g., fertility toxicity, early embryonic development toxicity, fetal development toxicity, perinatal toxicity, and maternal toxicity). As a result, current research offers limited guidance for the clinical application of Rhizoma Paridis, highlighting the need for further studies.

3.6 Long-term toxicity

Long-term toxicity studies of Rhizoma Paridis saponins have shown significant chronic toxicity, particularly affecting the liver and gastrointestinal systems. High doses (350 mg/kg) of Rhizoma Paridis saponins in rats led to weight loss, reduced food and water intake, indicating impaired gastrointestinal function. Prolonged exposure caused liver cell damage, oxidative stress, and elevated liver markers (ALT and AST), with the high-dose group showing the most severe effects. The medium and low doses (50 and 100 mg/kg) also caused some liver damage [86].

Although research on pulmonary toxicity is limited, other saponins from TCM suggest lung damage mechanisms involving inflammation and oxidative stress. Further studies are needed to assess pulmonary risks of Rhizoma Paridis saponins.

However, liver function in all dose groups returned to normal after a 4-week withdrawal, suggesting the chronic toxicity of Rhizoma Paridis saponins may be reversible, likely due to compensatory mechanisms like antioxidant system activation and tissue repair.

3.7 Summary

In summary, the hepatotoxicity, hemolysis, gastrointestinal toxicity, and cardiovascular toxicity associated with Rhizoma Paridis are primarily attributed to its saponin content. However, the severity and specific nature of these toxic effects vary among the different saponins present in Rhizoma Paridis, including Polyphyllin I, Polyphyllin II, and Polyphyllin Ⅶ [82,8789] (Table 2).

Table 2

Comparison of toxicity profiles of different Rhizoma Paridis saponins

Characteristic Polyphyllin I Polyphyllin II Polyphyllin VII
Toxicity intensity Strongest Moderate Weakest
Toxicity targets Liver, cardiovascular system, RBCs, kidneys, lungs, sperm Liver, kidneys, heart, sperm Liver, kidneys, sperm
Organ toxicity features Liver: severe liver toxicity, vacuolization, necrosis; heart: Severe cardiovascular toxicity, impacts heart rate, promotes cardiac cell apoptosis; Kidneys: Mild toxicity, no renal edema; lungs: Thickened alveolar walls Liver: Hepatocyte necrosis; kidneys: Mild tubular damage Liver: Mild hepatocyte vacuolization; kidneys: Slight lipid metabolism disorder
Experimental models Cells (heart, liver, kidney) Cells (heart, liver, kidney) Cells (heart, liver, kidney)
Zebrafish Zebrafish Zebrafish
LC50 121 ng/mL LC50 213 ng/mL LC50 570 ng/mL
LC10 109 ng/mL LC10 178 ng/mL LC10 456 ng/mL
MNLC 99 ng/mL MNLC 146 ng/mL MNLC 357 ng/mL
Mice LC50 24.5 mg/kg No data available No data available
Conclusion Significant toxicity with multiple targets, requires strict dose control, suitable for short-term applications, clinical use must be cautious, especially at high doses Relatively mild toxicity with concentrated targets, suitable for combination therapy or single-drug development Lowest toxicity, high potential for application, suitable for further clinical studies
References [8790] [8789] [87,89]

The inclusion of a comparison of the toxicity of different saponins is crucial because it helps to better understand the varying risks associated with Rhizoma Paridis. These saponins have unique pharmacological properties that contribute to different toxicity mechanisms. By identifying the specific saponins present in a formulation, clinicians can make more informed decisions regarding dosage, treatment regimens, and monitoring strategies. This comparison also highlights the need for individualized treatment plans, tailored to the specific toxicity risks posed by the particular saponin content, thereby optimizing therapeutic outcomes while minimizing adverse effects.

4 Toxicity prevention and treatment of Rhizoma Paridis

Understanding the toxicity of medicinal herbs and developing effective prevention and detoxification strategies are crucial in the application of TCM. Effective toxicity management not only enhances therapeutic efficacy but also ensures the safety of the treatment. This section reviews both traditional and modern detoxification methods for Rhizoma Paridis, critically evaluating their scientific potential and limitations, with the aim of providing guidance for its safe clinical use.

4.1 Considerations in the use of Rhizoma Paridis

Existing evidence suggests that Rhizoma Paridis possesses a certain degree of toxicity, necessitating careful attention to dosage control and appropriate usage methods.

4.1.1 Dosage control

Effective management of Rhizoma Paridis dosage is critical to mitigate potential toxicity risks. Clinical studies underscore the importance of strict dosage control, typically recommending a range of 3–9 g per administration. However, individualization of dosage is paramount, considering factors such as the patient’s age, body weight, health status, and tolerance levels. Overdosing on Rhizoma Paridis can lead to severe adverse reactions, particularly hepatotoxicity characterized by liver damage. Monitoring of liver enzymes and other relevant biomarkers during treatment is advisable to promptly detect and manage any emerging toxicity.

4.1.2 Contraindicated populations

Rhizoma Paridis should be avoided by pregnant and breastfeeding women, as well as individuals with impaired liver or kidney function. Populations with compromised metabolic and detoxification abilities, such as the malnourished or those with chronic diseases, are at heightened risk of toxic reactions and should use this herb with caution. Additionally, individuals with a history of allergies should avoid its use.

4.2 Methods of reducing toxicity

TCM has developed extensive strategies for managing toxicity, primarily through herbal combinations, preparation techniques, and formulation adjustments that reduce toxicity while enhancing efficacy.

4.2.1 Herb pairing for toxicity reduction

In TCM, herb pairing is a crucial strategy for enhancing therapeutic effects and mitigating toxicity [9092]. Rhizoma Paridis is often combined with other herbs to reduce its toxic effects. For example, pairing it with Glycyrrhiza and Curcuma longa can alleviate liver toxicity. Modern pharmacological studies suggest that the flavonoids in Glycyrrhiza can repair liver tissue by reducing inflammation, enhancing antioxidant enzyme activity, and decreasing oxidative stress in the liver. Furthermore, Glycyrrhiza saponins may also reduce oxidative stress and inflammation by inhibiting ROS production and regulating the NF-κB pathway, potentially reducing liver toxicity [93]. However, the specific detoxification mechanisms of Glycyrrhiza in combination with Rhizoma Paridis require further investigation.

C. longa has also shown potential in mitigating the toxicity of Rhizoma Paridis. Research indicates that combining C. longa with Rhizoma Paridis may alleviate toxicity in both the liver and lungs. The detoxification mechanism of C. longa likely involves the reduction of ROS, suppression of inflammatory markers, and activation of the Nrf2/HO-1 detoxification pathway. However, this mechanism needs further clinical and preclinical validation [94].

4.2.2 Processing methods for toxicity reduction

The processing of medicinal herbs plays a crucial role in reducing toxicity and enhancing efficacy. Proper preparation methods can decrease the toxicity of Rhizoma Paridis without compromising its therapeutic effects, while improper processing may exacerbate toxicity. For instance, vinegar processing of Rhizoma Paridis has been shown to reduce its gastrointestinal irritant effects. While traditional processing methods have demonstrated some effectiveness in reducing toxicity, they are not standardized, and scientific validation of their detoxifying effects is limited.

4.2.3 Application of modern scientific technologies

Modern pharmacology has provided important insights into the toxicological mechanisms of Rhizoma Paridis, facilitating the development of more precise preventive measures. Advanced toxicological evaluation techniques allow for a comprehensive understanding of Rhizoma Paridis’s toxic properties before clinical use, helping to minimize adverse reactions. The use of animal and cell models has expanded the scope of toxicity assessment, offering critical guidance for safe usage.

Innovative pharmaceutical technologies, such as microemulsions and liposomes, significantly improve the bioavailability of drugs while reducing liver damage. For instance, studies have demonstrated that encapsulating Saikosaponin D in liposomes can reduce its toxicity [95]. This approach may also provide a potential strategy for mitigating the toxicity of Rhizoma Paridis.

Additionally, modern research suggests that antioxidant supplements, such as Vitamin C and Vitamin E, can enhance liver detoxification and reduce oxidative stress associated with Rhizoma Paridis toxicity [96,97]. While these adjunctive treatments show promise in mitigating toxicity, further clinical data are needed to determine the best combinations of auxiliary herbs for use with Rhizoma Paridis.

4.3 Detoxification methods

When toxicity occurs, timely and effective detoxification measures are crucial to minimize damage. Upon poisoning, the use of Rhizoma Paridis must be immediately discontinued. Common detoxification methods, both traditional and modern, help reduce toxin absorption and promote elimination, thereby alleviating poisoning symptoms.

4.3.1 Traditional detoxification methods

TCM often employs herbal remedies for detoxification, including Scutellaria baicalensis, immature bitter orange, etc. [98,99]. S. baicalensis is known for its antioxidant, anti-inflammatory, and cell-regulating properties, which can alleviate liver damage caused by toxins. Modern pharmacological studies indicate that Scutellaria and its active compounds (such as baicalin) can synergize with other drugs to enhance efficacy, reduce toxicity, or overcome drug resistance [100,101]. Moreover, Chai Hu saponins can prevent liver toxicity induced by acetaminophen through inhibition of NF-κB and STAT3 signaling pathways. Licorice Decoction combined with rice vinegar and ginger juice are used for detoxifying Rhizoma Paridis poisoning [102].

Decoction therapy is a traditional detoxification method in Chinese medicine, with a rich history of clinical application. For example, in cases of poisoning from certain cardiac drugs (e.g., digoxin), the use of Shengmai San can help protect heart function [103]. Classic formulas such as Jiedu Tang, Huang Lian Jiedu Tang, and Da Cheng Qi Tang are commonly used to alleviate liver damage [104]. However, there is currently no specific formula available for liver injury caused by Rhizoma Paridis, indicating the need for further research to develop effective detoxification remedies. Decoctions, by gently promoting detoxification and facilitating the metabolism and excretion of toxins, are widely used in traditional clinical practice. However, their efficacy is often influenced by factors such as the patient’s constitution and the ratio of medicinal ingredients. Furthermore, a lack of scientific evidence for precision treatment calls for continued investigation to verify their effectiveness and clinical feasibility.

4.3.2 Modern detoxification methods

Advancements in modern medicine have introduced chemical detoxifiers and pharmaceutical technologies that offer new avenues for detoxification. These methods are typically more controllable and scientifically validated.

Common general detoxification treatments include gastric lavage, purgation, and the administration of diluted acetic acid. Gastric lavage effectively reduces toxin concentration in acute poisoning cases. For example, in cases of colchicine poisoning, where there is no clear distinction between toxic and lethal doses, clinicians often consider gastrointestinal decontamination or gastric lavage using activated charcoal [105].

Chemical detoxifiers, such as N-acetylcysteine (NAC), replenish glutathione levels and restore the liver’s antioxidant capacity, making it a cornerstone treatment for liver toxicity. Cholesterol inhibitors, such as lovastatin, have been shown to mitigate saponin-induced membrane damage by inhibiting HMGCR, thereby regulating cholesterol metabolism and stabilizing cholesterol levels within cell membranes. This stabilization helps alleviate hemolysis caused by saponins. Additionally, lovastatin provides hepatoprotective effects by reducing oxidative stress and inflammatory responses, thereby attenuating saponin-induced hepatotoxicity [106].

4.4 Comparison and integration of traditional and modern methods

Traditional detoxification methods, such as herb pairing and processing, offer advantages in the management of chronic toxicity, including lower costs and a wealth of historical experience. However, these methods lack molecular mechanism validation and their efficacy can vary across individuals. In contrast, modern methods like NAC and magnesium isoglycyrrhizinate offer more precise control over ROS and metabolic pathways, providing more effective solutions, particularly in the management of acute toxicity. However, modern methods are often costly and technically complex, limiting their widespread application in resource-constrained regions [107116] (Table 3). Future research should explore the integration of traditional and modern approaches, such as combining herbal pairings (e.g., Glycyrrhiza, C. longa) with modern pharmaceutical technologies (e.g., nanomedicines), to achieve synergistic detoxification and promote the combined use of both strategies.

Table 3

A comparative analysis of traditional and modern detoxification methods

Aspect Traditional methods Modern methods
Mechanism Based on herb combinations and processing Using molecular biology, enzyme inhibition, and modern detox mechanisms
Efficacy Relies on experience and intuition, adjusts overall effects Quality and toxicity controlled via instrument testing and standardization
Processing time and efficiency Long process, experience-based Fast, standardized, easy to monitor quality
Advantages Holistic approach, personalized treatment, accumulated historical experience Scientifically-based, quantifiable detox effects, fast, stable efficacy
Disadvantages Lack of scientific validation, unstable efficacy, long treatment time High cost, potential introduction of new toxicity
References [107112] [108,113116]

5 Evaluation of TCM toxicity

Although current toxicological studies provide a theoretical foundation for the clinical application of Rhizoma Paridis, they remain incomplete. Therefore, further research on its toxicity is essential. This section summarizes key aspects of toxicity studies for TCM, with the aim of offering more comprehensive guidance for the safe and effective use of Rhizoma Paridis.

5.1 Key aspects of toxicity studies

Key aspects of toxicity studies are essential for assessing the safety of a drug throughout its development, from preclinical to clinical stages. One critical area is acute and chronic toxicity, which involves evaluating the toxic effects of Rhizoma Paridis at varying doses and durations to identify both immediate and long-term risks. Another key aspect is organ-specific toxicity, where researchers examine the effects of Rhizoma Paridis on vital organs such as the liver, kidneys, and heart to assess potential organ damage. Reproductive toxicity assessments are also crucial, as they evaluate the herb’s impact on fertility and fetal development to ensure it does not adversely affect the reproductive system. Additionally, understanding the cytotoxic mechanisms at the cellular level is important for exploring how Rhizoma Paridis induces toxicity within cells, providing insights into how its harmful effects might be mitigated. Finally, studying drug interactions is vital for analyzing how Rhizoma Paridis interacts with other medications, as these interactions can influence its efficacy and safety profile, potentially leading to unexpected adverse effects. Together, these comprehensive toxicity studies form a solid foundation for the safe and effective clinical use of Rhizoma Paridis.

5.2 Research methods and techniques

The complexity of TCM components and their diverse biological targets necessitates the development of specialized safety assessment techniques tailored to the unique characteristics of TCM. Establishing these techniques is essential for conducting large-scale toxicity studies and achieving a comprehensive understanding of the potential risks associated with TCM.

5.2.1 Animal experiments

In TCM toxicity evaluations, rats and mice are commonly used for acute and subacute toxicity tests [117119]. However, due to the complexity and multiple targets of TCM components, traditional mammalian models present challenges such as high costs, long testing durations, and limitations in high-throughput screening capacity.

As an alternative, the chick embryo model has gained popularity due to its ease of manipulation, relative transparency, and accessibility, making it an ideal platform for high-throughput screening. The physiological and pathological changes in chick embryos can be visualized using techniques such as candling, staining, and imaging, bridging the gap between in vivo and in vitro studies. This has established chick embryos as valuable tools for pharmacodynamics and toxicity research in TCM [120].

In recent years, zebrafish have become widely used in TCM toxicity studies. The advantages of the zebrafish model include its low cost, short lifecycle, ease of high-throughput screening, and exemption from strict ethical regulations before 5 days post-fertilization [121]. Studies have demonstrated the applicability of zebrafish in assessing various toxicities, including acute, hepatic, cardiac, renal, developmental, neurological, gastrointestinal, immunological, and ototoxicity [122]. For instance, zebrafish models have been used to evaluate the nephrotoxicity of aristolochic acid, confirming the model’s stability and accuracy in TCM toxicity screening [123]. Zebrafish have also been employed to assess the toxicity of artemisinin compounds [124]. However, it is important to note that physiological differences limit the zebrafish model’s comprehensive application [125]. Researchers have applied zebrafish models to study the toxicity of Rhizoma Paridis, providing evidence of its toxic properties.

Overall, integrating traditional mammalian models, chick embryos, and zebrafish provides a multi-tiered evaluation system for Rhizoma Paridis toxicity research. The combined use of these models offers a more comprehensive understanding of the toxicological properties of Rhizoma Paridis, thereby supporting its safe and effective clinical application.

5.2.2 Cell experiments

Developing cell models that replicate in vivo responses is essential for advancing scientific research and improving ethical standards [126]. These in vitro models allow researchers to conduct drug screening and toxicity assessments more efficiently, reducing the ethical concerns and costs associated with animal experiments. For example, cardiomyocytes derived from embryonic stem cells or human-induced pluripotent stem cells are increasingly used to predict cardiotoxicity in the early stages of drug development [127].

Furthermore, the advancement of organoid technology provides new opportunities for evaluating the toxicity of TCM. Organoids are three-dimensional miniature organs formed through the self-organization of stem cells and can closely mimic the structure and function of actual organs. Researchers have successfully created cardiac tissue models to assess the impact of TCM on heart health, and similar platforms have been developed to evaluate TCM-induced nephrotoxicity using organoid technology and advanced cell models [128,129]. These platforms offer efficient and precise tools for studying the toxicity of Rhizoma Paridis.

By integrating traditional mammalian models with advanced in vitro systems, a comprehensive evaluation framework can be established for the toxicity research of Rhizoma Paridis. The application of these models will provide deeper insights into the toxicological properties of Rhizoma Paridis, supporting its safe and effective clinical use.

6 Discussion

Increasing evidence supports the potential of natural medicines in disease treatment [130138]. For example, Tu Youyou successfully extracted artemisinin from Chinese herbal medicine and applied it to treat malaria, saving millions of lives [139].

Rhizoma Paridis, a TCM with significant clinical potential, has shown promising preclinical therapeutic effects. Extensive research has demonstrated its pharmacological activities, including antitumor, anti-inflammatory, and antifibrotic effects [140142]. For instance, preclinical studies have shown that PPII not only inhibits tumor growth but also enhances sensitivity to treatment by inducing pyroptosis in tumor cells, exhibiting strong anticancer effects in models such as lung cancer [143145].

However, despite its great therapeutic potential, the toxicity of Rhizoma Paridis remains a major obstacle to its widespread application, particularly in relation to liver, cardiovascular, and gastrointestinal side effects [146]. Existing research mainly focuses on acute toxicity, while data on chronic toxicity are insufficient. Long-term use, particularly at high doses or over extended periods, may lead to additional adverse effects. Therefore, further investigation into its chronic toxicity is necessary to clarify the potential long-term risks to human health. Despite these concerns, when used within the recommended dosage range, Rhizoma Paridis demonstrates significant therapeutic effects, especially in treating cancer and immune system disorders. In fact, Rhizoma Paridis and its formulations have been used clinically with favorable outcomes. For example, Loulian capsules for primary liver cancer and Jinfukang oral liquid for primary non-small cell lung cancer have shown positive results. Clinical studies indicate that when administered at appropriate doses, the toxicity of Rhizoma Paridis is minimal, and it can effectively alleviate related symptoms. Therefore, it is crucial for clinicians to precisely control the dosage, develop individualized treatment plans, and closely monitor patients’ physiological responses to ensure safety. However, we also highlighted the need for additional clinical trials and randomized controlled studies to further confirm the efficacy and safety of Rhizoma Paridis, ensuring its rational use in clinical settings. We believe that such studies are essential to establish clearer guidelines for its application in clinical practice.

As research into the toxicological mechanisms of TCM advances, the safety and efficacy of Rhizoma Paridis can be further improved, contributing to the development of TCM and standardizing its clinical applications. Current TCM toxicity research mainly relies on cell and animal experiments; however, with the development of modern technologies such as network pharmacology and machine learning, valuable insights into the toxicological mechanisms of TCM will emerge in the future [147].

Additionally, with the rapid development of modern drug delivery systems, innovative technologies are emerging that not only enhance the bioavailability of drugs but also reduce their toxicity. Poly lactic-co-glycolic acid (PLGA) nanoparticles, a drug delivery system known for its excellent biocompatibility and controlled release properties, can significantly improve the solubility and targeting of drugs. For Rhizoma Paridis, combining modern drug delivery technology, especially the co-loading of PPII and IR780 into PLGA nanoparticles, effectively overcomes the limitations of traditional drug delivery, such as solubility and targeting issues. This delivery system enables high concentrations of PPII and IR780 to accumulate at tumor sites, and, through the photothermal effect of IR780, precisely kill tumor cells under laser irradiation. Furthermore, the pyroptotic effect induced by PPII, in combination with the photothermal therapy from IR780, generates a synergistic effect, enhancing anticancer efficacy while reducing toxicity to normal cells, thereby improving the safety and effectiveness of the treatment [148].

By integrating modern drug delivery technology with the traditional therapeutic effects of TCM, we can maximize the therapeutic potential of Rhizoma Paridis while minimizing its toxicity, thus promoting its safe clinical application.

7 Future and prospectives

In summary, Rhizoma Paridis shows great potential as a medicinal herb, but more research is needed to fully understand its effects and safety. Future studies should focus on understanding how it works in the body and its long-term effects, especially since most research has looked at short-term toxicity. It is also important to study its chronic toxicity to ensure that it is safe for long-term use. Combining traditional knowledge with modern research methods like systems biology could help identify key pathways and biomarkers for both its benefits and risks. Additionally, strategies to reduce toxicity, such as improving how the herb is processed or combining it with other herbs, should be explored. Researchers should also look into how Rhizoma Paridis interacts with other drugs and its effects on drug metabolism. Ultimately, clinical trials will be necessary to confirm its safety and effectiveness in real-world use. By addressing these areas, future research can help ensure that Rhizoma Paridis is used safely and effectively in medical practice.


tel: +86-08733113300

Acknowledgments

The authors are grateful for the reviewer’s valuable comments that improved the manuscript.

  1. Funding information: The funding for this study was provided by various sources, including the Yunnan Province “Xing Dian Ying Talent” Support Programme Project (XDYC- MY- 2022-070), Provincial Science and Technology Department Kunming Medical Joint Special Project – Key Project (202301AY070001-037).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and consented to its submission to the journal, reviewed all the results and approved the final version of the manuscript. SJW provided guidance, conceptualized the study, and contributed significantly to the writing and execution of the manuscript. ZGW and DZF participated in data acquisition, manuscript writing, and critical revision of the work. ZY contributed to data acquisition. ZMY focused on data analysis and interpretation. LHF coordinated communication among co-authors throughout the submission, review, and production process, secured final approval from all authors, and took accountability for the originality, accuracy, and integrity of every part of the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Li J, Jia J, Zhu W, Chen J, Zheng Q, Li D. Therapeutic effects on cancer of the active ingredients in Rhizoma Paridis. Front Pharmacol. 2023;14:1095786.Search in Google Scholar

[2] Read BE. The Chinese pharmacopoeia. Can Med Assoc J. 1930;23(4):568.Search in Google Scholar

[3] Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, et al. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol. 2021;14(1):187.10.1186/s13045-021-01200-4Search in Google Scholar PubMed PubMed Central

[4] Guan X. Advances in research on chemical constituents and pharmacological effects of Paris genus and prediction and analysis of quality markers. Chin Tradit Herb Drugs. 2019;10:4838–52.Search in Google Scholar

[5] Wu S, Gao W, Duan H, Jia W. Progress in the study of chemical composition and pharmacological action of Chonglou. Chin Herb Med. 2004;35:344–7.Search in Google Scholar

[6] Yu S, Wang L, Cao Z, Gong D, Liang Q, Chen H, et al. Anticancer effect of polyphyllin I in colorectal cancer cells through ROS-dependent autophagy and G2/M arrest mechanisms. Nat Product Res. 2018;32(12):1489–92.10.1080/14786419.2017.1353512Search in Google Scholar PubMed

[7] Zhang Q, Bi H, Xie L. Research advances in pharmacological action and clinical applications of Paris polyphylla. Med Recapitulate. 2018;24:4113–7.Search in Google Scholar

[8] Qin XJ, Yu MY, Ni W, Yan H, Chen CX, Cheng YC, et al. Steroidal saponins from stems and leaves of Paris polyphylla var. yunnanensis. Phytochemistry. 2016;121:20–9.10.1016/j.phytochem.2015.10.008Search in Google Scholar PubMed

[9] Cai B, Zhang Y, Wang Z, Xu D, Jia Y, Guan Y, et al. Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances. Oxid Med Cell Longev. 2020;2020:3153082.10.1155/2020/3153082Search in Google Scholar PubMed PubMed Central

[10] Cheng G, Xue Y-Y, Fang F, Sun G-Q, Lu Y-Y, Ji Y-Q, et al. Promotion of Ros-mediated Bax/Cyt-c apoptosis by polyphyllin II leads to suppress growth and aggression of glioma cells. Transl Cancer Res. 2021;10(9):3894.10.21037/tcr-21-966Search in Google Scholar PubMed PubMed Central

[11] Kiasalari Z, Rahmani T, Mahmoudi N, Baluchnejadmojarad T, Roghani M. Diosgenin ameliorates development of neuropathic pain in diabetic rats: involvement of oxidative stress and inflammation. Biomed Pharmacother. 2017;86:654–61.10.1016/j.biopha.2016.12.068Search in Google Scholar PubMed

[12] Lee B-K, Kim C-J, Shin M-S, Cho YS. Diosgenin improves functional recovery from sciatic crushed nerve injury in rats. J Exercise Rehabil. 2018;14(4):566.10.12965/jer.1836340.170Search in Google Scholar PubMed PubMed Central

[13] Liu H, Gu LB, Tu Y, Hu H, Huang YR, Sun W. Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy. Acta Pharmacol Sin. 2016;37(2):235–45.10.1038/aps.2015.114Search in Google Scholar PubMed PubMed Central

[14] Man S, Li J, Fan W, Chai H, Liu Z, Gao W. Inhibition of pulmonary adenoma in diethylnitrosamine-induced rats by Rhizoma Paridis saponins. J Steroid Biochem Mol Biol. 2015;154:62–7.10.1016/j.jsbmb.2015.07.004Search in Google Scholar PubMed

[15] Huang N, He HW, He YY, Gu W, Xu MJ, Liu L. Xiaotan Sanjie recipe, a compound Chinese herbal medicine, inhibits gastric cancer metastasis by regulating GnT-V-mediated E-cadherin glycosylation. J Integr Med. 2023;21(6):561–74.10.1016/j.joim.2023.11.001Search in Google Scholar PubMed

[16] Zhu LM, Shi HX, Sugimoto M, Bandow K, Sakagami H, Amano S, et al. Feiyanning formula induces apoptosis of lung adenocarcinoma cells by activating the mitochondrial pathway. Front Oncol. 2021;11:690878.10.3389/fonc.2021.690878Search in Google Scholar PubMed PubMed Central

[17] Liu S-T, Yu H, Hou A-J, Man W-J, Zhang J-X, Wang S, et al. A review of the pharmacology, application, ethnopharmacology, phytochemistry, quality control, processing, toxicology, and pharmacokinetics of paridis rhizoma. World J Tradit Chin Med. 2022;8(1):21–49.10.4103/wjtcm.wjtcm_4_21Search in Google Scholar

[18] Wang Q, Li C, Cao Z, Yang X. Network-based analysis of Jinfukang in the treatment of lung cancer. Eur J Integr Med. 2021;41:101232.10.1016/j.eujim.2020.101232Search in Google Scholar

[19] Yang J. Progress in clinical application of Changchun Hongyao Capsule. ClRes Tradit ChMed. 2019;11(36):135–6+46.Search in Google Scholar

[20] Zhao Y, Zhang B, Fu Y, Xie Z, Ma X, Hou B, et al. The study on the formulation principles of prescription compositions containing Chonglou. Chin Tradit Pat Med. 2025;47(4):1–8.Search in Google Scholar

[21] Wang YH, Shi M, Niu HM, Yang J, Xia MY, Luo JF, et al. Substituting one Paris for another? In vitro cytotoxic and in vivo antitumor activities of Paris forrestii, a substitute of Paris polyphylla var. yunnanensis. J Ethnopharmacol. 2018;218:45–50.10.1016/j.jep.2018.02.022Search in Google Scholar PubMed

[22] Qiu P, Man S, Yang H, Fan W, Yu P, Gao W. Utilization of metabonomics to identify serum biomarkers in murine H22 hepatocarcinoma and deduce antitumor mechanism of Rhizoma Paridis saponins. Chem-biol Interact. 2016;256:55–63.10.1016/j.cbi.2016.06.026Search in Google Scholar PubMed

[23] Guo D, Guo C, Fang L, Sang T, Wang Y, Wu K, et al. Qizhen capsule inhibits colorectal cancer by inducing NAG-1/GDF15 expression that mediated via MAPK/ERK activation. J Ethnopharmacol. 2021;273:113964.10.1016/j.jep.2021.113964Search in Google Scholar PubMed

[24] Zhou W, Yu X, Zhang Z, Wang X, Nie C, Zhang G, et al. Uncovering the key targets and therapeutic mechanisms of qizhen capsule in gastric cancer through network pharmacology and bioinformatic analyses. Comput Math Methods Med. 2022;2022:1718143.10.1155/2022/1718143Search in Google Scholar PubMed PubMed Central

[25] Jiang Y, Lao H, Wang R, Zhu X, Zhao Y, Liu J, et al. Efficacy of chonglou shenghua decoction concentrate-granules in preventing lochia after cesarean section. China Pharmacist. 2021;24(6):1091–4.Search in Google Scholar

[26] Ma M, Lv F, Tian L, Guo J. Clinical effect analysis of Gongxuening capsule on bleeding after family planning operation. Panminerva Med. 2024;66(1):115–6.10.23736/S0031-0808.20.04248-2Search in Google Scholar PubMed

[27] Sun XH, Liu S. External Chinese medical therapy for pain associated with hyperplastic disease of the breast: study protocol of a randomized, double-blind, multicenter, controlled trial. J Chin Integr Med. 2012;10(4):384–9.10.3736/jcim20120406Search in Google Scholar PubMed

[28] Wang Y. Effects of Antivenom combined ShiWei Sheshang QingduPill and Liangxue Jiedu Ointmenttion treatment ofTrimeresurus albolabris bite. Beijing, China: China Academic Journal (CD-ROM) Electronic Publishing House Co., Ltd.; 2022.Search in Google Scholar

[29] Zhang JL, Wang H, Pi HF, Ruan HL, Zhang P, Wu JZ. Structural analysis and antitussive evaluation of five novel esters of verticinone and bile acids. Steroids. 2009;74(4–5):424–34.10.1016/j.steroids.2008.12.007Search in Google Scholar PubMed

[30] Li L, Zhang J, Cheng W, Di F, Wang C, An Q. Saponins of paris polyphylla for the improvement of acne: anti-inflammatory, antibacterial, antioxidant and immunomodulatory effects. Molecules. 2024;29(8):1793.10.3390/molecules29081793Search in Google Scholar PubMed PubMed Central

[31] Yang J, Wang X, Wu D, Yi K, Zhao Y. Yunnan Baiyao-loaded multifunctional microneedle patches for rapid hemostasis and cutaneous wound healing. J Nanobiotechnol. 2023;21(1):178.10.1186/s12951-023-01936-wSearch in Google Scholar PubMed PubMed Central

[32] Qiao X, Qu C, Luo Q, Wang Y, Yang J, Yang H, et al. UHPLC-qMS spectrum-effect relationships for Rhizoma Paridis extracts. J Pharm Biomed Anal. 2021;194:113770.10.1016/j.jpba.2020.113770Search in Google Scholar PubMed

[33] Yin W, Song ZR, Liu JQ, Zhang GS. Chemical constituents of Paris polyphylla var. chinensis aerial parts. J Chin Med Mater. 2015;38(9):1875–8.Search in Google Scholar

[34] Ling Y, Fu Z, Zhang Q, Xu L, Liao L. Identification and structural elucidation of steroidal saponins from the root of Paris polyphylla by HPLC-ESI-QTOF-MS/MS. Nat product Res. 2015;29(19):1798–803.10.1080/14786419.2015.1007137Search in Google Scholar PubMed

[35] Wu X, Wang L, Wang H, Dai Y, Ye W-C, Li Y-L. Steroidal saponins from Paris polyphylla var. yunnanensis. Phytochemistry. 2012;81:133–43.10.1016/j.phytochem.2012.05.034Search in Google Scholar PubMed

[36] Bouabdallah S, Al-Maktoum A, Amin A. Steroidal saponins: naturally occurring compounds as inhibitors of the hallmarks of cancer. Cancers. 2023;15(15):3900.10.3390/cancers15153900Search in Google Scholar PubMed PubMed Central

[37] Bhuia MS, Chowdhury R, Sonia FA, Kamli H, Shaikh A, El-Nashar HAS, et al. Anticancer potential of the plant-derived saponin gracillin: a comprehensive review of mechanistic approaches. Chem Biodiversity. 2023;20(9):e202300847.10.1002/cbdv.202300847Search in Google Scholar PubMed

[38] Wu X, Wang L, Wang G-C, Wang H, Dai Y, Ye W-C, et al. New steroidal saponins and sterol glycosides from Paris polyphylla var. yunnanensis. Planta Med. 2012;78(15):1667–75.10.1055/s-0032-1315239Search in Google Scholar PubMed

[39] Wei JC, Gao WY, Yan XD, Wang Y, Jing SS, Xiao PG. Chemical constituents of plants from the genus Paris. Chem Biodivers. 2014;11(9):1277–97.10.1002/cbdv.201300083Search in Google Scholar PubMed

[40] Kang L-P, Liu Y-X, Eichhorn T, Dapat E, Yu H-s, Zhao Y, et al. Polyhydroxylated steroidal glycosides from Paris polyphylla. J Nat Products. 2012;75(6):1201–5.10.1021/np300045gSearch in Google Scholar PubMed

[41] Wen Y-S, Ni W, Qin X-J, Yan H, Chen C-X, Hua Y, et al. Steroidal saponins with cytotoxic activity from the rhizomes of Paris polyphylla var. yunnanensis. Phytochem Lett. 2015;12:31–4.10.1016/j.phytol.2015.02.011Search in Google Scholar

[42] Jin LY, Lu TX, Qin XJ, Ni W, Yan H, Chen Y, et al. Two new highly oxygenated spirostanol saponins from Paris polyphylla var. stenophylla. Nat Prod Bioprospect. 2016;6(4):205–10.10.1007/s13659-016-0102-xSearch in Google Scholar PubMed PubMed Central

[43] Li X, Zhang M, Xiang C, Li BC, Li P. Antiepileptic C21 steroids from the roots of Cynanchum otophyllum. J Asian Nat Products Res. 2015;17(7):724–32.10.1080/10286020.2014.1001380Search in Google Scholar PubMed

[44] Peng W, Liang S, Hu J, Chen Z, Zheng X. The cytotoxic and tyrosine kinase inhibitory properties of C21 steroids and iridoids from the tubers of Alocasia cucullata. J Nat Med. 2016;70(3):602–9.10.1007/s11418-016-0982-4Search in Google Scholar PubMed

[45] Zhuang ZR, Wang ML, Peng YR, Shen MQ. Effect of C21 steroidal glycoside of Cynanchum auriculatum on liver and kidney fibrosis through TLR4 pathway. China J Chin Mater Meda. 2021;46(11):2857–64.Search in Google Scholar

[46] Qin X-J, Chen C-X, Ni W, Yan H, Liu H-Y. C22-steroidal lactone glycosides from stems and leaves of Paris polyphylla var. yunnanensis. Fitoterapia. 2013;84:248–51.10.1016/j.fitote.2012.12.007Search in Google Scholar PubMed

[47] Wang Y, Yuan H, Fan S. Optimization of extraction technique for total flavonoids from Paris polyphylla. J South Agric. 2017;48(4):698–703.Search in Google Scholar

[48] Li YM, Guan LJ, Chen LM, Zhao M, Ding LS, Meng CX, et al. Qualitative and quantitative analysis of Paris polyphylla var. chinensis by UPLC-Q-TOF-MS/MS and HPLC. China J Chin Mater Med. 2021;46(12):2900–11.Search in Google Scholar

[49] Ding YG, Zhao YL, Zhang J, Zuo ZT, Zhang QZ, Wang YZ. The traditional uses, phytochemistry, and pharmacological properties of Paris L. (Liliaceae):a review. J Ethnopharmacol. 2021;278:114293.10.1016/j.jep.2021.114293Search in Google Scholar PubMed

[50] Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol : CB. 2017;27(21):R1147–51.10.1016/j.cub.2017.09.019Search in Google Scholar PubMed PubMed Central

[51] Piñeiro-Carrero VM, Piñeiro EO. Liver. Pediatrics. 2004;113(4 Suppl):1097–106.10.1542/peds.113.S3.1097Search in Google Scholar

[52] Papich MG, Davis LE. Drugs and the liver. Vet Clin North Am Small Anim Pract. 1985;15(1):77–95.10.1016/S0195-5616(85)50005-4Search in Google Scholar

[53] Iorga A, Dara L, Kaplowitz N. Drug-induced liver injury: cascade of events leading to cell death, apoptosis or necrosis. Int J Mol Sci. 2017;18(5):1018.10.3390/ijms18051018Search in Google Scholar PubMed PubMed Central

[54] Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discovery. 2005;4(6):489–99.10.1038/nrd1750Search in Google Scholar PubMed

[55] Jia Z, Zhao C, Wang M, Zhao X, Zhang W, Han T, et al. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome. Biomed Pharmacother. 2020;121:109558.Search in Google Scholar

[56] Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007;14(7):1237–43.10.1038/sj.cdd.4402148Search in Google Scholar PubMed

[57] Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol. 2004;16(11):1095–105.10.1097/00042737-200411000-00003Search in Google Scholar PubMed

[58] Wang W, Dong X, You L, Sai N, Leng X, Yang C, et al. Apoptosis in HepaRG and HL-7702 cells inducted by polyphyllin II through caspases activation and cell-cycle arrest. J Cell Physiol. 2019;234(5):7078–89.10.1002/jcp.27462Search in Google Scholar PubMed

[59] Ni B, Wang W, Liu M, Xu Y, Zhao J. Paris saponin Ⅰ induce toxicity in zebrafish by up-regulation of p53 pathway and down-regulation of wnt pathway. Toxicon. 2023;228:107094.10.1016/j.toxicon.2023.107094Search in Google Scholar PubMed

[60] Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 2018;19(1):38–54.10.2174/1389450118666170125144557Search in Google Scholar PubMed

[61] Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Family Phys. 2007;76(3):391–6.Search in Google Scholar

[62] Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology--with emphasis on cytochrome p450. Toxicol Sci. 2011;120(1):1–13.10.1093/toxsci/kfq374Search in Google Scholar PubMed

[63] Hart DW, Gore DC, Rinehart AJ, Asimakis GK, Chinkes DL. Sepsis-induced failure of hepatic energy metabolism1 1Project funded by grant #8270 from Shriners Hospitals for Children. J Surg Res. 2003;115(1):139–47.10.1016/S0022-4804(03)00284-1Search in Google Scholar PubMed

[64] Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A, et al. Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. Nanomedicine. 2019;17:210–22.10.1016/j.nano.2019.01.013Search in Google Scholar PubMed

[65] Shi C, Xue W, Han B, Yang F, Yin Y, Hu C. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. Eur J Pharmacol. 2019;850:15–22.10.1016/j.ejphar.2019.02.005Search in Google Scholar PubMed

[66] Jia Z, Zhao C, Wang M, Zhao X, Zhang W, Han T, et al. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome. Biomed Pharmacother. 2020;121:109558.10.1016/j.biopha.2019.109558Search in Google Scholar PubMed

[67] Dausset J, Contu L. Drug-induced hemolysis. Annu Rev Med. 1967;18:55–70.10.1146/annurev.me.18.020167.000415Search in Google Scholar PubMed

[68] Carstairs K. Drug-induced immune haemolysis. Proc R Soc Med. 1968;61(12):1309–11.10.1177/003591576806101236Search in Google Scholar PubMed PubMed Central

[69] Lam WK, Yip SF. Drug-induced oxidative hemolysis. N Engl J Med. 2024;390(16):1513.10.1056/NEJMicm2312581Search in Google Scholar PubMed

[70] Behling-Kelly E. Identifying erythrocyte injury in toxicology studies. Toxicol Pathol. 2022;50(7):883–5.10.1177/01926233221127942Search in Google Scholar PubMed

[71] Bay P, Buob D, Modot T, Gabarre P, Doreille A, Rafat C. Antineoplastic drug-induced immune hemolytic anemia resulting in acute kidney injury: lesson for the clinical nephrologist. J Nephrol. 2023;36(6):1693–7.10.1007/s40620-023-01600-4Search in Google Scholar PubMed

[72] Ata F, Magboul HMB, Toba HAA, Alfar H, Al Bozom A, Murshed K, et al. Rifampin-induced acute kidney injury and hemolysis: a case report and literature review of a rare condition. Clin Case Rep. 2022;10(12):e6780.10.1002/ccr3.6780Search in Google Scholar PubMed PubMed Central

[73] Liu Z, Li N, Gao W, Man S, Yin S, Liu C. Comparative study on hemostatic, cytotoxic and hemolytic activities of different species of Paris L. J Ethnopharmacol. 2012;142(3):789–94.10.1016/j.jep.2012.05.065Search in Google Scholar PubMed

[74] Böttger S, Melzig MF. The influence of saponins on cell membrane cholesterol. Bioorg Med Chem. 2013;21(22):7118–24.10.1016/j.bmc.2013.09.008Search in Google Scholar PubMed

[75] Jennings ML. Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1. Am J Physiol Cell Physiol. 2021;321(6):C1028–c59.10.1152/ajpcell.00275.2021Search in Google Scholar PubMed PubMed Central

[76] Kulin A, Kucsma N, Bohár B, Literáti-Nagy B, Korányi L, Cserepes J, et al. Genetic modulation of the GLUT1 transporter expression-potential relevance in complex diseases. Biology. 2022;11(11):1669.10.3390/biology11111669Search in Google Scholar PubMed PubMed Central

[77] Ning L, Zhou B, Zhang Y, Li X. Study on hemolytic mechanism of polyphyllin Ⅱ. China J Chin Mater Med. 2015;40(18):3623–9.Search in Google Scholar

[78] Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B, et al. Polyphyllin D induces apoptosis in human erythrocytes through Ca²⁺ rise and membrane permeabilization. Arch Toxicol. 2012;86(5):741–52.10.1007/s00204-012-0808-4Search in Google Scholar PubMed

[79] Liu Z, Gao W, Man S, Wang J, Li N, Yin S, et al. Pharmacological evaluation of sedative–hypnotic activity and gastro-intestinal toxicity of Rhizoma Paridis saponins. J Ethnopharmacol. 2012;144(1):67–72.10.1016/j.jep.2012.08.027Search in Google Scholar PubMed

[80] Johnson IT, Gee JM, Price K, Curl C, Fenwick GR. Influence of saponins on gut permeability and active nutrient transport in vitro. J Nutr. 1986;116(11):2270–7.10.1093/jn/116.11.2270Search in Google Scholar PubMed

[81] Michel L, Rassaf T. Drug-induced cardiomyopathies. Dtsch Med Wochenschr. 19462022;147(23):1513–22.10.1055/a-1810-9275Search in Google Scholar PubMed

[82] Wang W. Toxicity Evaluation of Rhyacophilus Saponins I, II, and VII and Investigation of the Hepatotoxic Mechanism of Rhyacophilus Saponin I 2021.Search in Google Scholar

[83] Wang W, Liu Y, You L, Sun M, Qu C, Dong X, et al. Inhibitory effects of Paris saponin I, II, Ⅵ and Ⅶ on HUVEC cells through regulation of VEGFR2, PI3K/AKT/mTOR, Src/eNOS, PLCγ/ERK/MERK, and JAK2-STAT3 pathways. Biomed Pharmacother. 2020;131:110750.Search in Google Scholar

[84] Shen F, Yang L, Peng Y, Quan X, Ma Y. Study on the antifertility effect of the saponins in rhizoma paridis yunnanensis [Rhizoma from Paris polyphylla Smith var.yunnanensis(Franch) Hand.-Mazz. in Vitro. Mod Appl Pharmacol China. 2010;27(11):961–4.Search in Google Scholar

[85] Yang W, Xiao B, Yu X, Han L. Research progress on reproductive toxicity of toxic traditional Chinese Research progress on reproductive toxicity of toxic traditional Chinese. Chin J Pharmacol Toxicol. 2018;32(05):355–63.Search in Google Scholar

[86] Fan W. Study on anti-hepatocarcinoma and safety evaluation of Phizoma Paridis Saponins and tis compound. Beijing, China: China Academic Journal (CD-ROM) Electronic Publishing House Co., Ltd.; 2015.Search in Google Scholar

[87] Wang W, Liu Y, You L, Sun M, Qu C, Dong X, et al. Inhibitory effects of Paris saponin I, II, Ⅵ and Ⅶ on HUVEC cells through regulation of VEGFR2, PI3K/AKT/mTOR, Src/eNOS, PLCγ/ERK/MERK, and JAK2-STAT3 pathways. Biomed Pharmacother = Biomed Pharmacother. 2020;131:110750.10.1016/j.biopha.2020.110750Search in Google Scholar PubMed

[88] Li Z, Fan Q, Chen M, Dong Y, Li F, Wang M, et al. The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway. J Pharm Anal. 2023;13(1):39–54.10.1016/j.jpha.2022.11.005Search in Google Scholar PubMed PubMed Central

[89] Wang X, Chen L, Lin R, Chen M, Fan Q, Li Z, et al. Developmental toxicity, anti-angiogenesis activity and mechanism of polyphyllinI on zebrafish. Chin Herb Med. 2023;54(14):4548–55.Search in Google Scholar

[90] Liu Y, Zhong QX, Qiu HH, Wang G, Wang CC, Feng L, et al. Study on attenuating hepatotoxicity of Tripterygium wilfordii through compatibility of traditional Chinese medicine compound. J Chin Mater Med. 2017;42(16):3044–8.Search in Google Scholar

[91] Zhang Q, Li Y, Liu M, Duan J, Zhou X, Zhu H. Compatibility with panax notoginseng and rehmannia glutinosa alleviates the hepatotoxicity and nephrotoxicity of Tripterygium wilfordii via modulating the pharmacokinetics of triptolide. Int J Mol Sci. 2018;19(1):305.10.3390/ijms19010305Search in Google Scholar PubMed PubMed Central

[92] Tian YG, Su XH, Liu LL, Kong XY, Lin N. Overview of hepatotoxicity studies on Tripterygium wilfordii in recent 20 years. J Chin Mater Med. 2019;44(16):3399–405.Search in Google Scholar

[93] Shi Y, Zhang Y, Lin J, Xu K, Li C, Li P. Research progress in TCM-induced liver injury. Kangganranyaoxue. 2024;21(03):228–31.Search in Google Scholar

[94] Liu Z, Gao W, Man S, Zhang Y, Li H, Wu S, et al. Synergistic effects of Rhizoma Paridis and Rhizoma Curcuma longa on different animal tumor models. Environ Toxicol Pharmacol. 2014;38(1):31–40.10.1016/j.etap.2014.04.026Search in Google Scholar PubMed

[95] Shiu LY, Huang HH, Chen CY, Cheng HY, Chen CI, Kuo SM. Reparative and toxicity-reducing effects of liposome-encapsulated saikosaponin in mice with liver fibrosis. Biosci Rep. 2020;40(8):BSR20201219.10.1042/BSR20201219Search in Google Scholar PubMed PubMed Central

[96] Naziroğlu M, Cay M, Ustündağ B, Aksakal M, Yekeler H. Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct. 1999;17(4):253–9.10.1002/(SICI)1099-0844(199912)17:4<253::AID-CBF837>3.0.CO;2-RSearch in Google Scholar

[97] Sclafani L, Shimm P, Edelman J, Seifter E, Levenson SM, Demetriou AA. Protective effect of vitamin E in rats with acute liver injury. JPEN J Parenter Enteral Nutr. 1986;10(2):184–7.10.1177/0148607186010002184Search in Google Scholar

[98] Zhou X, Fu L, Wang P, Yang L, Zhu X, Li CG. Drug–herb interactions between Scutellaria baicalensis and pharmaceutical drugs: insights from experimental studies, mechanistic actions to clinical applications. Biomed Pharmacother = Biomed Pharmacother. 2021;138:111445.10.1016/j.biopha.2021.111445Search in Google Scholar

[99] Ahmadi A, Mortazavi Z, Mehri S, Hosseinzadeh H. Scutellaria baicalensis and its constituents baicalin and baicalein as antidotes or protective agents against chemical toxicities: a comprehensive review. Naunyn-Schmiedeberg's Arch Pharmacol. 2022;395(11):1297–329.10.1007/s00210-022-02258-8Search in Google Scholar

[100] Zhou H-C, Wang H, Shi K, Li J-M, Zong Y, Du R. Hepatoprotective effect of baicalein against acetaminophen-induced acute liver injury in mice. Molecules. 2019;24(1):131.10.3390/molecules24010131Search in Google Scholar

[101] Zhao Y, Li H, Gao Z, Gong Y, Xu H. Effects of flavonoids extracted from Scutellaria baicalensis Georgi on hemin–nitrite–H2O2 induced liver injury. Eur J Pharmacol. 2006;536(1):192–9.10.1016/j.ejphar.2006.02.045Search in Google Scholar

[102] Liu A, Tanaka N, Sun L, Guo B, Kim JH, Krausz KW, et al. Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling. Chemico-biol Interact. 2014;223:80–6.10.1016/j.cbi.2014.09.012Search in Google Scholar

[103] Mao JY, Liu CX, Wang HH, Wei GL, Zhang ZP, Xing J, et al. Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. J Chin Integr Med. 2010;8(11):1070–4.10.3736/jcim20101111Search in Google Scholar

[104] Lv Y, Wang J, Xu D, Liao S, Li P, Zhang Q, et al. Comparative study of single/combination use of Huang-Lian-Jie-Du decoction and berberine on their protection on sepsis induced acute liver injury by NMR metabolic profiling. J Pharm Biomed Anal. 2017;145:794–804.10.1016/j.jpba.2017.07.062Search in Google Scholar

[105] Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol. 2010;48(5):407–14.10.3109/15563650.2010.495348Search in Google Scholar

[106] Li Z, Tang Y, Liu Z, Fan Q, Chen M, Lin Z, et al. Hepatotoxicity induced by PPⅥ and PPⅦ in zebrafish were related to the cholesterol disorder. Phytomedicine. 2022;95:153787.10.1016/j.phymed.2021.153787Search in Google Scholar PubMed

[107] Chan YT, Wang N, Feng Y. The toxicology and detoxification of Aconitum: traditional and modern views. Chin Med. 2021;16(1):61.10.1186/s13020-021-00472-9Search in Google Scholar PubMed PubMed Central

[108] Yeih DF, Chiang FT, Huang SK. Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart. 2000;84(4):E8.10.1136/heart.84.4.e8Search in Google Scholar PubMed PubMed Central

[109] Lu X, Zhang L, Li P, Wang J, Li R, Huang Y, et al. The protective effects of compatibility of Aconiti Lateralis Radix Praeparata and Zingiberis Rhizoma on rats with heart failure by enhancing mitochondrial biogenesis via Sirt1/PGC-1α pathway. Biomed Pharmacother. 2017;92:651–60.10.1016/j.biopha.2017.05.117Search in Google Scholar PubMed

[110] Xie S, Zhang G, Sun G, Zhu X, Chen R, Zhang S, et al. [Detoxication experimental study on different compatibility proportion of Aconiti Lateralis Radix Praeparata and glycyrrhizae radix et rhizoma]. China J Chin Mater Med. 2012;37(15):2210–4.Search in Google Scholar

[111] Liu M, Cao Y, Lv D, Zhang W, Zhu Z, Zhang H, et al. Effect of processing on the alkaloids in Aconitum tubers by HPLC-TOF/MS. J Pharm Anal. 2017;7(3):170–5.10.1016/j.jpha.2017.01.001Search in Google Scholar PubMed PubMed Central

[112] Shan Q, Yu W, Xu Q, Liu R, Ying S, Dong J, et al. Detoxification and underlying mechanisms towards toxic alkaloids by Traditional Chinese Medicine processing: a comprehensive review. Phytomedicine. 2024;129:155623.10.1016/j.phymed.2024.155623Search in Google Scholar PubMed

[113] Lv X, Xia Y, Finel M, Wu J, Ge G, Yang L. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharm Sin B. 2019;9(2):258–78.10.1016/j.apsb.2018.09.005Search in Google Scholar PubMed PubMed Central

[114] Cao Z, Liu B, Li L, Lu P, Yan L, Lu C. Detoxification strategies of triptolide based on drug combinations and targeted delivery methods. Toxicology. 2022;469:153134.10.1016/j.tox.2022.153134Search in Google Scholar PubMed

[115] Chen X, Wu R, Jin H, Gao R, Yang B, Wang Q. Successful rescue of a patient with acute aconitine poisoning complicated by polycystic renal hemorrhage. J Nippon Med Sch. 2015;82(5):257–61.10.1272/jnms.82.257Search in Google Scholar PubMed

[116] Lee SO, Kim SJ, Kim JS, Ji H, Lee EO, Lee HJ. Comparison of the main components and bioactivity of Rhus verniciflua Stokes extracts by different detoxification processing methods. BMC Complementary Altern Med. 2018;18(1):242.10.1186/s12906-018-2310-xSearch in Google Scholar PubMed PubMed Central

[117] Zhao L, Li P, Xu H, Han B, Chen J, Gao Z, et al. Toxicological safety evaluation in acute and 28-day studies of aqueous extract from Bei-Qi-Wu-Jia formula. J Ethnopharmacol. 2020;248:112324.10.1016/j.jep.2019.112324Search in Google Scholar PubMed

[118] Wang Q, Zhao L, Zhang H, Zhang S, Yang P, Wang H, et al. Acute toxicity and safety profile evolution of aqueous extracts of Sanren decoction using in vivo models. J Ethnopharmacol. 2022;287:114940.10.1016/j.jep.2021.114940Search in Google Scholar PubMed

[119] Li W, Jiang H, Ablat N, Wang C, Guo Y, Sun Y, et al. Evaluation of the acute and sub-chronic oral toxicity of the herbal formula xiaoer chaigui tuire oral liquid. J Ethnopharmacol. 2016;189:290–9.10.1016/j.jep.2016.05.050Search in Google Scholar PubMed

[120] Wu T, Yu GY, Xiao J, Yan C, Kurihara H, Li YF, et al. Fostering efficacy and toxicity evaluation of traditional Chinese medicine and natural products: chick embryo as a high throughput model bridging in vitro and in vivo studies. Pharmacol Res. 2018;133:21–34.10.1016/j.phrs.2018.04.011Search in Google Scholar PubMed

[121] Lai KP, Gong Z, Tse WKF. Zebrafish as the toxicant screening model: transgenic and omics approaches. Aquat Toxicol. 2021;234:105813.10.1016/j.aquatox.2021.105813Search in Google Scholar PubMed

[122] Sarasamma S, Varikkodan MM, Liang ST, Lin YC, Wang WP, Hsiao CD. Zebrafish: a premier vertebrate model for biomedical research in Indian Scenario. Zebrafish. 2017;14(6):589–605.10.1089/zeb.2017.1447Search in Google Scholar PubMed

[123] Chen M, Zhao C, Li Z, Fan Q, Lu S, Tao X, et al. Investigation of the applicability of the zebrafish model for the evaluation of aristolochic acid-related nephrotoxicity. Phytomedicine. 2023;121:155092.10.1016/j.phymed.2023.155092Search in Google Scholar PubMed

[124] Gu L, Wang X, Shao X, Ding Y, Li Y. Study on chemical constituents of Folium Artemisiae argyi Carbonisatum, toxicity evaluation on zebrafish and intestinal hemostasis. Saudi Pharmaceutical J : SPJ: Off Publ Saudi Pharmaceutical Soci. 2022;30(5):532–43.10.1016/j.jsps.2022.02.018Search in Google Scholar PubMed PubMed Central

[125] Zhang Y, Xia Q, Wang J, Zhuang K, Jin H, Liu K. Progress in using zebrafish as a toxicological model for traditional Chinese medicine. J Ethnopharmacol. 2022;282:114638.10.1016/j.jep.2021.114638Search in Google Scholar PubMed

[126] Stefanowicz AJ, Recio L, Black MB, Beames T, Andersen ME, Stern RA, et al. Comparison of rat hepatocyte 2d-monocultures and hepatocytes non-parenchymal cell co-cultures for assessing chemical toxicity. Int J Toxicol. 2023;42(1):19–36.10.1177/10915818221139471Search in Google Scholar PubMed

[127] Li X, Zhang R, Zhao B, Lossin C, Cao Z. Cardiotoxicity screening: a review of rapid-throughput in vitro approaches. Arch Toxicol. 2016;90(8):1803–16.10.1007/s00204-015-1651-1Search in Google Scholar PubMed

[128] Sun HK, Gao Y, Zhu MJ, Tang JF, Wu Y, Li B, et al. hiPSCs and organoids: prediction of arrhythmogenic risks for optimized traditional Chinese medicine. China J Chin Mater Med. 2023;48(20):5404–9.Search in Google Scholar

[129] Gu S, Wu G, Lu D, Meng G, Wang Y, Tang L, et al. Nephrotoxicity assessment of Esculentoside A using human-induced pluripotent stem cell-derived organoids. Phytother Res. 2023;38(10):4893–903.10.1002/ptr.7721Search in Google Scholar PubMed

[130] Bo S, Zhang M, Dan M. The traditional use, structure, and immunostimulatory activity of bioactive polysaccharides from traditional Chinese root medicines: a review. Heliyon. 2024;10(1):e23593.10.1016/j.heliyon.2023.e23593Search in Google Scholar PubMed PubMed Central

[131] Bai W, Wang Z, Liang J, Deng H. Atractylodes macrocephala-paeonia lactiflora class formula for the treatment of irritable bowel syndrome: a systematic review with meta-analysis and trial sequential analysis. Cureus. 2023;15(12):e49997.10.7759/cureus.49997Search in Google Scholar PubMed PubMed Central

[132] Zheng HZ, Chang TY, Peng B, Ma SQ, Zhong Z, Cao JZ, et al. Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: a scoping review. Complement Ther Med. 2024;80:103014.10.1016/j.ctim.2024.103014Search in Google Scholar PubMed

[133] Lin QR, Jia LQ, Lei M, Gao D, Zhang N, Sha L, et al. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: an update since 2010. Pharmacol Res. 2024;200:107054.10.1016/j.phrs.2023.107054Search in Google Scholar PubMed

[134] Du R, Achi JG, Cui Q, Rong L. Paving new roads toward the advancement of broad-spectrum antiviral agents. J Med Virol. 2024;96(1):e29369.10.1002/jmv.29369Search in Google Scholar PubMed

[135] Ma J, Li Q, Wang T, Lu H, Liu J, Cai R, et al. A comprehensive review of Shengdeng in Tibetan medicine: textual research, herbal and botanical distribution, traditional uses, phytochemistry, and pharmacology. Front Pharmacol. 2023;14:1303902.10.3389/fphar.2023.1303902Search in Google Scholar PubMed PubMed Central

[136] Cao Q, Dong P, Han H. Therapeutic effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease. Psychogeriatrics. 2024;24:443–57.10.1111/psyg.13051Search in Google Scholar PubMed

[137] Zhou G, Liu H, Yuan Y, Wang Q, Wang L, Wu J. Lentinan progress in inflammatory diseases and tumor diseases. Eur J Med Res. 2024;29(1):8.10.1186/s40001-023-01585-7Search in Google Scholar PubMed PubMed Central

[138] Feng L, Shi Y, Zou J, Zhang X, Zhai B, Guo D, et al. Recent advances in Platycodon grandiflorum polysaccharides: preparation techniques, structural features, and bioactivities. Int J Biol Macromol. 2024;259(Pt 1):129047.10.1016/j.ijbiomac.2023.129047Search in Google Scholar PubMed

[139] Tu Y. Artemisinin-a gift from traditional Chinese medicine to the world (Nobel Lecture). Angew Chem. 2016;55(35):10210–26.10.1002/anie.201601967Search in Google Scholar PubMed

[140] Ke F, Zhang R, Chen R, Guo X, Song C, Gao X, et al. The role of Rhizoma Paridis saponins on anti-cancer: the potential mechanism and molecular targets. Heliyon. 2024;10(17):e37323.10.1016/j.heliyon.2024.e37323Search in Google Scholar PubMed PubMed Central

[141] Li J, Jia J, Zhu W, Chen J, Zheng Q, Li D. Therapeutic effects on cancer of the active ingredients in Rhizoma Paridis. Front pharmacology. 2023;14:1095786.10.3389/fphar.2023.1095786Search in Google Scholar PubMed PubMed Central

[142] Hong Y, Han YQ, Wang YZ, Gao JR, Li YX, Liu Q, et al. Paridis Rhizoma Sapoinins attenuates liver fibrosis in rats by regulating the expression of RASAL1/ERK1/2 signal pathway. J Ethnopharmacol. 2016;192:114–22.10.1016/j.jep.2016.07.010Search in Google Scholar PubMed

[143] Peng L, Yang R, Wang Z, Jian H, Tan X, Li J, et al. Polyphyllin II (PPII) enhances the sensitivity of multidrug-resistant a549/ddp cells to cisplatin by modulating mitochondrial energy metabolism. In Vivo. 2024;38(1):213–25.10.21873/invivo.13428Search in Google Scholar PubMed PubMed Central

[144] Li JK, Sun HT, Jiang XL, Chen YF, Zhang Z, Wang Y, et al. Polyphyllin II induces protective autophagy and apoptosis via inhibiting PI3K/AKT/mTOR and STAT3 signaling in colorectal cancer cells. Int J Mol Sci. 2022;23(19):11890.10.3390/ijms231911890Search in Google Scholar PubMed PubMed Central

[145] Wu J, Ding Z, Zhong M, Xi J, He Y, Zhang B, et al. Polyphyllin II induces apoptosis in fibrosarcoma cells via activating pyruvate kinase M2. Chem Res Toxicol. 2024;37(8):1394–403.10.1021/acs.chemrestox.4c00154Search in Google Scholar PubMed

[146] Kundu P, Das S, Chattopadhyay N. Managing efficacy and toxicity of drugs: targeted delivery and excretion. Int J Pharmaceutics. 2019;565:378–90.10.1016/j.ijpharm.2019.04.058Search in Google Scholar PubMed

[147] Zhu KX, Wu M, Bian ZL, Han SL, Fang LM, Ge FF, et al. Growing attention on the toxicity of Chinese herbal medicine: a bibliometric analysis from 2013 to 2022. Front Pharmacol. 2024;15:1293468.10.3389/fphar.2024.1293468Search in Google Scholar PubMed PubMed Central

[148] Huang H, Fu J, Peng H, He Y, Chang A, Zhang H, et al. Co-delivery of polyphyllin II and IR780 PLGA nanoparticles induced pyroptosis combined with photothermal to enhance hepatocellular carcinoma immunotherapy. J Nanobiotechnol. 2024;22(1):647.10.1186/s12951-024-02887-6Search in Google Scholar PubMed PubMed Central

Received: 2024-09-10
Revised: 2024-12-31
Accepted: 2025-01-10
Published Online: 2025-11-27

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  3. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  4. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  5. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  6. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  7. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  8. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  9. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  10. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  11. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  12. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  13. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  14. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  15. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  16. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  17. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  18. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  19. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  20. Changes in blood glucose and metabolism in hyperuricemia mice
  21. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  22. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  23. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  24. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  25. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  26. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  27. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  28. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  29. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  30. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  31. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  32. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  33. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  34. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  35. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  36. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  37. Low-pressure exposure influences the development of HAPE
  38. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  39. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  40. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  41. A case of bloodstream infection caused by Neisseria gonorrhoeae
  42. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  43. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  44. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  45. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  46. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  47. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  48. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  49. Sodium butyrate aids brain injury repair in neonatal rats
  50. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  51. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  52. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  53. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  54. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  55. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  56. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  57. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  58. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  59. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  60. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  61. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  62. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  63. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  64. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  65. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  66. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  67. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  68. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  69. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  70. Oncolytic bacteria: A revolutionary approach to cancer therapy
  71. A de novo meningioma with rapid growth: A possible malignancy imposter?
  72. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  73. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  74. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  75. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  76. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  77. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  78. Evaluation and application analysis of animal models of PIPNP based on data mining
  79. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  80. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  81. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  82. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  83. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  84. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  85. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  86. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  87. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  88. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  89. RNF144A and RNF144B: Important molecules for health
  90. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  91. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  92. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  93. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  94. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  95. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  96. Understanding risk factors and prognosis in diabetic foot ulcers
  97. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  98. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  99. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  100. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  101. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  102. Pulmonary cryptococcosis with headache as the first presentation: A case report
  103. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  104. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  105. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  106. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  107. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  108. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  109. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  110. Wound healing and signaling pathways
  111. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  112. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  113. Research progress on the impact of curcumin on immune responses in breast cancer
  114. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  115. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  116. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  117. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  118. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  119. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  120. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  121. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  122. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  123. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  124. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  125. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  126. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  127. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  128. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  129. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  130. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  131. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  132. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  133. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  134. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  135. Advances in cancer immunotherapy and future directions in personalized medicine
  136. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  137. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  138. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  139. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  140. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  141. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  142. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  143. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  144. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  145. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  146. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  147. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  148. Ecology and Environmental Science
  149. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  150. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  151. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  152. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  153. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  154. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  155. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  156. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  157. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  158. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  159. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  160. Agriculture
  161. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  162. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  163. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  164. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  165. Animal Science
  166. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  167. Plant Sciences
  168. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  169. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  170. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  171. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  172. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  173. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  174. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  175. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  176. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  177. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  178. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  179. Food Science
  180. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  181. Review on role of honey in disease prevention and treatment through modulation of biological activities
  182. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  183. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  184. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  185. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  186. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  187. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  188. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  189. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  190. The dilemma of food genetics and improvement
  191. Bioengineering and Biotechnology
  192. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  193. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  194. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  195. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  196. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  197. Corrigendum
  198. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  199. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  200. Retraction
  201. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 12.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-1055/html
Scroll to top button